CTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Captor Therapeutics SA

Watchlist Manager

Watchlist

Price: 74.2 PLN -0.54% Market Closed

Market Cap: zł471.2m

C	Captor Therapeutics SA WSE:CTX	PL
R	Resolute Mining Ltd DUS:RSM	AU
	Artisanal Spirits Company PLC F:045	UK
	Mcphy Energy SA PAR:MCPHY	FR
6	60 Degrees Pharmaceuticals Inc NASDAQ:SXTP	US
A	Allcore SpA MIL:CORE	IT
	Mcphy Energy SA F:M6P	FR
T	technotrans SE XMUN:TTR1	DE
	Mcphy Energy SA PAR:ALMCP	FR
Y	Yem Chio Co Ltd TWSE:4306	TW

Profitability Summary

Captor Therapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

76%

Strong 3Y Average Gross Margin

64%

Declining Gross Margin

84% > 76%

Negative Operating Margin

-1 852%

Negative 3Y Average Operating Margin

-567%

Declining Operating Margin

-579% > -1 852%

Negative Net Margin

-1 791%

Negative 3Y Average Net Margin

-548%

Declining Net Margin

-539% > -1 791%

Negative Free Cash Flow Margin

-3 072%

Negative 3Y Average Free Cash Flow Margin

-509%

Declining Free Cash Flow Margin

-397% > -3 072%

Negative ROE

-110%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-464%

Declining ROIC

-507% > -759%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.